RESEARCH ON THE IMMUNOPATHOLOGICAL MECHANISMS OF VOGT-KOYANAGI-HARADA DISEASE

VOGT-小柳-原田病的免疫病理机制研究

基本信息

  • 批准号:
    06671757
  • 负责人:
  • 金额:
    $ 1.15万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

Vogt-Koyanagi-Harada disease (VKH) is thought to be a systemic disorder affecting various organs containing melanocytes. Melanocyte-specific cytotoxic T lymphocytes (CTL) in VKH have been assumed to be generated and to play an important role in the manifestation of this disease.We established melanoma-specific CTL cell lines from patients with VKH by long term culture of peripheral blood leukocytes with melanoma under IL-2 stimulation. The CTL activity of these cell lines against melanoma was inhibited by the anti-HLA-DR monoclonal antibody, whereas the monoclonal antibody specific for monomorphic determinants of HLA-A,B,and C failed to block lytic activity. Flow cytometric analysis revealed that the surface markers of these cell lines were CD4^+CD8^-HLA_-DR^+CD25^+TCRalphabeta^+TCRgammadelta^-. These cell lines produced extremely high level of IL-6 and Signifioant levels of IL-2 and IFN-gamma.mRNA of IL-2 was detected in the CTLs. Thus, melanoma-specific HLA-DR-restricted T-helper 1 CTLs may play a role in the immunopathogenesis of VKH.We assessed T cell subsets in the peripheral blood and aqueous humor from patients with VKH by using three-color flow cytometry. Although the percentage of CD4^+CD45RA^+ cells within T cells was rare in aqueous humor compared with peripheral blood, the percentage of CD4^+CD29^+ or CD4^+ CD45RO^+ (memory) cells in aqueous humor was much higher than in peripheral blood. Fas antigen, a cell-surface molecule that mediated apoptosis, was expressed preferentially on CD4^+CD45RO^+ cells in aqueous humor. Out results suggest that the accumulation of Fas^+CD4^+CD45RO^+ T lymphocytes in aqueous humor reflects the immunopathological mechanism of VKH.
沃格特-小柳-原田病 (VKH) 被认为是一种影响多种含有黑素细胞的器官的系统性疾病。据认为,VKH 中会产生黑色素细胞特异性细胞毒性 T 淋巴细胞 (CTL),并在该疾病的表现中发挥重要作用。我们通过在 IL-2 刺激下长期培养黑色素瘤外周血白细胞,从 VKH 患者中建立了黑色素瘤特异性 CTL 细胞系。这些细胞系针对黑色素瘤的 CTL 活性受到抗 HLA-DR 单克隆抗体的抑制,而对 HLA-A、B 和 C 的单态决定簇特异的单克隆抗体则未能阻断裂解活性。流式细胞分析显示这些细胞系的表面标志物为CD4^+CD8^-HLA_-DR^+CD25^+TCRalphabeta^+TCRgammadelta^-。这些细胞系产生极高水平的IL-6以及显着水平的IL-2和IFN-γ。在CTL中检测到IL-2的mRNA。因此,黑色素瘤特异性 HLA-DR 限制性 T 辅助细胞 1 CTL 可能在 VKH 的免疫发病机制中发挥作用。我们使用三色流式细胞术评估了 VKH 患者外周血和房水中的 T 细胞亚群。尽管与外周血相比,房水中T细胞内CD4^+CD45RA^+细胞的百分比很少,但房水中CD4^+CD29^+或CD4^+CD45RO^+(记忆)细胞的百分比远高于外周血。 Fas抗原是一种介导细胞凋亡的细胞表面分子,优先在房水中的CD4^+CD45RO^+细胞上表达。结果表明,房水中Fas^+CD4^+CD45RO^+ T淋巴细胞的积累反映了VKH的免疫病理学机制。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kazumi Norose: "Dominance of activated T cells and IL-6 in agueous bunor in Vogt-Koyanagi-Harada disease" Invest Ophthelmol Vis Sci. 35. 33-39 (1994)
Kazumi Norose:“Vogt-Koyanagi-Harada 病中水性布诺尔中活化 T 细胞和 IL-6 的优势”Invest Ophthelmol Vis Sci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Norose K,Yano A,Wang X-c, Tokushima T,Umihira J,seki A,Nohara M,and Segawa K: "Dominance of activated T cells and interleukin-6in aqueous humor in Vogt-Koyanagi-Harada disease." Invest Ophthalmol Vis Sci. 35. 33-39 (1994)
Norose K、Yano A、Wang X-c、Tokushima T、Umihira J、seki A、Nohara M 和 Sekawa K:“Vogt-Koyanagi-Harada 病中房水中活化 T 细胞和白细胞介素 6 的优势。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tian-Hui Yang: "Enhanced cytotovicity of IFN-γ-producing CD4^+ cytofoxic T lymphoufee specific for T gondii-infected human melonone cells" J. Immunol. 154. 290-298 (1995)
Tian-Hui Yang:“增强对弓形虫感染的人瓜酮细胞产生 IFN-γ 的 CD4^+ 细胞毒性 T 淋巴细胞的细胞毒性”,J.Immunol. 154. 290-298 (1995)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kazumi Norose: "Dominance of activated T cells and IL-6 in aqueous hunor in Vogt-Koyanagi-Harada disease" Invest Ophthalmol Vis Sci. 35. 33-39 (1994)
Kazumi Norose:“Vogt-Koyanagi-Harada 病中房水中活化 T 细胞和 IL-6 的优势”Invest Ophasemol Vis Sci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fumie Aosai: "Comparative study of intenferon-σ production-by Toxoplasme gondiio infected B lymplome cell-specific CD8^+ CTL and Toxophlasme gondii-infected meland cell-specific DC8^+CTL" Jpn J Parasitol. 44. 210-217 (1995)
Fumie Aosai:“弓形虫感染的 B 淋巴瘤细胞特异性 CD8^+ CTL 和弓形虫感染的 meland 细胞特异性 DC8^+ CTL 产生干扰素的比较研究” Jpn J Parasitol. 44. 210-217 (1995) )
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NOROSE Kazumi其他文献

NOROSE Kazumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NOROSE Kazumi', 18)}}的其他基金

Establishment of the detection method for the reactivation of toxoplasmosis and the evaluatiion method for the severity of toxoplasmosis by mass spectrometer
弓形虫病再激活检测方法及质谱仪评价弓形虫病严重程度方法的建立
  • 批准号:
    17KT0124
  • 财政年份:
    2017
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of mechanisms of protozoan invasion into the retinal endothelium of congenital toxoplasmic retinochoroiditis
先天性弓形虫性视网膜脉络膜炎原虫侵入视网膜内皮机制分析
  • 批准号:
    20592071
  • 财政年份:
    2008
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular pathogenetic analysis of blood vessels in toxoplasmic retinochoroiditis
弓形虫性视网膜脉络膜炎血管分子发病机制分析
  • 批准号:
    17591822
  • 财政年份:
    2005
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
cDNA microarray analysis of toxoplasmic retinochoroiditis
弓形虫性视网膜脉络膜炎的cDNA微阵列分析
  • 批准号:
    14571657
  • 财政年份:
    2002
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effect of Heart Shock Protein and Interferon on Toxoplasmic Chorioretinitis
心休克蛋白与干扰素对弓形虫性脉络膜视网膜炎的影响
  • 批准号:
    12671697
  • 财政年份:
    2000
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
RESERCH ON THE RELATIONSHIP BETWEEN THE CELLULAR IMMUNITY AND CLINCAL PICTURE ON VOGT-KOYANAGI-HARADA DISEASE.
VOGT-小柳-原田病细胞免疫与临床表现之间关系的研究。
  • 批准号:
    04671070
  • 财政年份:
    1992
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

The role of distal aqueous humor outflow tissue in glucocorticoid-induced glaucoma
远端房水流出组织在糖皮质激素诱发青光眼中的作用
  • 批准号:
    10667863
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.
房水液体活检对视网膜母细胞瘤儿童分子预测和监测的验证。
  • 批准号:
    10718932
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
Regulation of aqueous humor flow by exosomal miRNA
外泌体 miRNA 对房水流动的调节
  • 批准号:
    23K09011
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of experimental basis to improve the prognosis of corneal transplantation in treating bullous keratoplasty due to pathological aqueous humor.
为改善角膜移植治疗病理性房水所致大疱性角膜移植术的预后奠定实验基础。
  • 批准号:
    23H03063
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Modulating aqueous humor outflow with engineered nanoparticles for glaucoma
用工程纳米颗粒调节房水流出以治疗青光眼
  • 批准号:
    10649763
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
  • 批准号:
    10510279
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
  • 批准号:
    10682543
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
人眼的动态可变房水流出和青光眼治疗
  • 批准号:
    10155489
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
ocular tissue response by intraocular pressure and aqueous humor in glaucoma - investigation for the mechanism and biomarkers of intraocular pressure regulation
青光眼中眼压和房水引起的眼组织反应——眼压调节机制和生物标志物的研究
  • 批准号:
    20H03839
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
人眼的动态可变房水流出和青光眼治疗
  • 批准号:
    10405079
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了